About Rodney

Rodney serves as the managing partner of McKinsey's offices in the Northeast United States (New York, Boston, and Stamford). He was previously leader of our Healthcare Systems and Services Practice. He advises clients across the healthcare spectrum, working with leading companies in pharmaceuticals, health insurance and healthcare-benefit management, as well as hospital systems and academic medical centers. He also serves clients across industries on growth strategy.

Rodney has helped develop strategies for clients responding to major market disruptions, such as US healthcare reform, and R&D productivity challenges. He has worked extensively on mergers and acquisitions, partnerships, organizational transformation, and post-merger integrations. He has also supported launch and growth strategies for a number of leading products in the United States, Europe, and Japan, helping deliver important benefits to patients and improved business results for clients. He has led McKinsey's support for a number of private-equity clients investing in healthcare.

Rodney has authored articles in leading healthcare business publications such as Nature Drug Discovery and In Vivo on the topics of R&D and innovation. He contributes to research efforts by the McKinsey Global Institute and is a frequent speaker at industry conferences.

Published work

"Changing the nature of board engagement," McKinsey Quarterly, April 2015

"Invention reinvented," McKinsey perspectives on pharmaceutical R&D, 2010

"The great rebalancing," McKinsey Quarterly, June 2010

"The productivity imperative," McKinsey Quarterly, June 2010

"The global grid," McKinsey Quarterly, June 2010

"The market state," McKinsey Quarterly, June 2010

Contributor, Shaping the future: Solving social problems through business strategy (a CECP report)


Trinity College, Cambridge University
PhD, molecular biology

Trinity College, Cambridge University
MA, natural sciences, first class